PCSA · Processa Pharmaceuticals, Inc. · Documents
$1.81
-0.05 (-2.69%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 14, 2026
The latest filing states the doubt was alleviated.
“Following our acquisition of Vidya and closing of the related $200 million gross private placement (from which we received net proceeds of $183.3 million) on July 30, 2026, we believe our cash and cash equivalents will be sufficient to satisfy our cash requirements over the next 12 months and beyond. This represents a material change from what we reported in our 2025 Form 10-K that disclosed substantial doubt of our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$5.06M
Shares
2.79M
Volume · Oct 23
35.05K
Avg daily vol (3M)
266.29K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-03-25 | — | |
| 10-K | — | 2021-03-25 | 2020-12-31 | |
| 8-K | — | 2021-02-18 | 2021-02-16 | |
| 8-K | — | 2021-01-11 | — | |
| 10-Q | — | 2020-11-12 | 2020-09-30 | |
| 8-K | — | 2020-11-05 | 2020-11-03 | |
| 8-K | — | 2020-10-13 | 2020-10-06 | |
| 8-K | — | 2020-10-06 | 2020-10-01 | |
| S-1/A | — | 2020-09-30 | — | |
| S-1/A | — | 2020-09-17 | — | |
| 8-K | — | 2020-08-27 | 2020-08-23 | |
| 8-K | — | 2020-08-20 | — | |
| 10-Q | — | 2020-08-05 | 2020-06-30 | |
| S-1/A | — | 2020-07-17 | — | |
| 8-K | — | 2020-06-01 | — | |
| 8-K | — | 2020-05-28 | 2020-05-27 | |
| 10-Q | — | 2020-05-15 | 2020-03-31 | |
| 8-K | — | 2020-03-30 | — | |
| 8-K | — | 2020-03-17 | — | |
| 10-K | — | 2020-03-06 | 2019-12-31 | |
| 8-K | — | 2020-03-05 | — | |
| 8-K | — | 2020-02-25 | — | |
| 8-K | — | 2020-02-13 | — | |
| 8-K | — | 2020-01-14 | — |
Showing 151–174 of 174 filings